Science 37 Holdings Inc. (NASDAQ: SNCE) stock fell -1.20% on Wednesday to $0.72 against a previous-day closing price of $0.73. With 0.31 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.3 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $0.7400 whereas the lowest price it dropped to was $0.6571. The 52-week range on SNCE shows that it touched its highest point at $14.44 and its lowest point at $0.68 during that stretch. It currently has a 1-year price target of $3.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SNCE was down-trending over the past week, with a drop of -14.83%, but this was down by -49.18% over a month. Three-month performance dropped to -60.13% while six-month performance fell -77.73%. The stock lost -92.35% in the past year, while it has lost -94.21% so far this year. A look at the trailing 12-month EPS for SNCE yields -0.72 with Next year EPS estimates of -0.53. For the next quarter, that number is -0.18. This implies an EPS growth rate of -197.80% for this year and 25.40% for next year.
Float and Shares Shorts:
At present, 116.41 million SNCE shares are outstanding with a float of 87.69 million shares on hand for trading. On Oct 13, 2022, short shares totaled 2.24 million, which was 1.92% higher than short shares on Sep 14, 2022. In addition to Mr. David Coman as the firm’s CEO & Director, Ms. Christine A. Pellizzari J.D. serves as its Chief Legal Officer & Sec..
Through their ownership of 58.72% of SNCE’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 6.48% of SNCE, in contrast to 36.65% held by mutual funds. Shares owned by individuals account for 17.78%. As the largest shareholder in SNCE with 17.02% of the stake, Redmile Group LLC holds 19,808,234 shares worth 19,808,234. A second-largest stockholder of SNCE, RTW Investments LP, holds 4,328,387 shares, controlling over 3.72% of the firm’s shares. Walleye Capital LLC is the third largest shareholder in SNCE, holding 4,017,763 shares or 3.45% stake. With a 1.79% stake in SNCE, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 2,085,291 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 1.09% of SNCE stock, is the second-largest Mutual Fund holder. It holds 1,265,298 shares valued at 1.83 million. Vanguard Extended Market Index Fu holds 0.61% of the stake in SNCE, owning 712,362 shares worth 1.03 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SNCE since 5 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With SNCE analysts setting a high price target of $5.00 and a low target of $2.00, the average target price over the next 12 months is $3.00. Based on these targets, SNCE could surge 594.44% to reach the target high and rise by 177.78% to reach the target low. Reaching the average price target will result in a growth of 316.67% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. SNCE will report FY 2022 earnings on 03/21/2023. Analysts have provided yearly estimates in a range of -$0.07 being high and -$0.10 being low. For SNCE, this leads to a yearly average estimate of -$0.09. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Science 37 Holdings Inc. surprised analysts by $0.01 when it reported -$0.20 EPS against a consensus estimate of -$0.21. The surprise factor in the prior quarter was $0.19. Based on analyst estimates, the high estimate for the next quarter is -$0.21 and the low estimate is -$0.24. The average estimate for the next quarter is thus -$0.22.
Summary of Insider Activity:
Insiders traded SNCE stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 9 while that of sell transactions has risen to 2 over the past year. The total number of shares bought during that period was 6,697,708 while 9,386,895 shares were sold.